• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON DICKINSON, S.A. BD DISCARDIT¿ II 20 ML SYRINGE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON DICKINSON, S.A. BD DISCARDIT¿ II 20 ML SYRINGE Back to Search Results
Catalog Number 300296
Device Problem Device Contamination with Chemical or Other Material (2944)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 09/23/2021
Event Type  malfunction  
Manufacturer Narrative
A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
 
Event Description
It was reported that at least one bd discardit¿ ii 20 ml syringe experienced foreign matter in the syringe.The following information was provided by the initial reporter: the customer informed that there were white flake kind of particles in the 20 ml discardit syringe, once pulling the plunger out.This has been noted in several 20 ml syringes.
 
Manufacturer Narrative
The following fields were updated due to additional information: d.9.Device available for eval?: yes.D.9.Returned to manufacturer on: 11/15/2021.H.6.Investigation: a device history record review was performed for provided lot number 2106269 and the review did not reveal any detected quality issues during the production process that could have contributed to this reported incident.To aid in the investigation of this issue, both pictures and the affected physical samples were returned for evaluation by our quality engineer team.Through examination of the samples, white flakes were observed within the syringe.We have concluded that the particles are composed of the slip agent used in the manufacture of this syringe product.This slip agent is used to facilitate the movement of the plunger along the barrel.During the manufacturing process, the lubricant forms a microscopic layer in the internal/external walls of the barrel.When the plunger is moved backwards during the filling of the syringe, most of this microscopic layer of lubricant is dragged behind the plunger and a small quantity still remains inside to allow a good sliding performance during the injection operation.This is a normal process and the syringe would not work without the presence of this lubricant.The most restrictive food additives regulations from different countries allow a maximum level of 0.2 % of lubricant.The specification for the quantity of lubricant used in the barrel of bd two piece syringes is below this limit.A toxicologic material risk assessment for the slip agents used in bd discardit ii 2-piece syringes indicate an extremely low to negligible risk of adverse effect in this clinical application.Based on the evaluation conducted, it is concluded that the reported white particles are inherent to the product design and material and should not represent any risk if the product is used according to the normal clinical practices.
 
Event Description
It was reported that at least one bd discardit¿ ii 20 ml syringe experienced foreign matter in the syringe.The following information was provided by the initial reporter: the customer informed that there were white flake kind of particles in the 20 ml discardit syringe, once pulling the plunger out.This has been noted in several 20 ml syringes.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD DISCARDIT¿ II 20 ML SYRINGE
Type of Device
SYRINGE
Manufacturer (Section D)
BECTON DICKINSON, S.A.
cr mequinenza
s/n
fraga, huesca 22520
SP  22520
Manufacturer (Section G)
BECTON DICKINSON, S.A.
cr mequinenza
s/n
fraga, huesca 22520
SP   22520
Manufacturer Contact
katie swenson
9450 south state street
sandy, UT 84070
8015296192
MDR Report Key12675862
MDR Text Key277894530
Report Number3002682307-2021-00566
Device Sequence Number1
Product Code FMF
Combination Product (y/n)N
Reporter Country CodeFI
PMA/PMN Number
NA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 03/03/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/21/2021
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Catalogue Number300296
Device Lot Number2106269
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/03/2022
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured06/23/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-